Charles Sawyers and colleagues have conducted a small early-stage clinical study to assess target modulation by the small-molecule inhibitor rapamycin. Rapamycin is approved to treat renal cancer ...
One such drug is rapamycin, a pill that is typically prescribed to patients ahead of organ transplants "to bring the immune ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback